Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mechanisms of Caffeine on Exercise-Induced Muscle Damage Force Loss
NCT02125643Phase 1Terminated
- Sponsor
- University of Oklahoma
- Start
- Aug 2014
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in exercise-induced muscle damage (EIMD) comparing Caffeine with Placebo (2 arms). Primary endpoint: Change in Maximal Voluntary Strength at 48 hours. Started Aug 2014; status: terminated.
02
Drugs
caffeine
03
Conditions
exercise-induced muscle damage (EIMD)
Beyond the preview
Go deeper on NCT02125643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02125643.